ÂÜÀòÂÒÂ×

Matthew Everly, PharmD has an extensive work experience spanning over several prestigious organizations. Matthew is currently serving as the Senior Director of Global Portfolio Strategy and Evidence Generation at Hansa Biopharma since December 2022. Before this, they held the position of Senior Global Evidence Generation and Solutions Director at the same company from May 2021 to December 2022.

Prior to joining Hansa Biopharma, Matthew worked as the Director of Global Evidence & Outcomes at Takeda Oncology from July 2020 to May 2021. In 2020, they also founded Cleverly Health LLC, where they served as the Founder and Principal until April 2021.

Matthew has a strong academic background and has held adjunct professor positions at the University of California, Los Angeles. Matthew served as the Adjunct Associate Professor of Medicine from July 2019 to November 2020 and as the Adjunct Assistant Professor of Medicine from May 2012 to July 2019.

Before their academic roles, Matthew held significant positions at the Terasaki Research Institute and One Lambda, Inc. | A Thermo Fisher Scientific Brand. At the Terasaki Research Institute, they served as the Institute Director (chief executive) from August 2014 to April 2020 and as a Senior Research Scientist at the Terasaki Foundation Laboratory from August 2012 to August 2014. At One Lambda, they held the role of Chief Scientific Officer from September 2010 to August 2012.

Matthew's career also includes a role as a Research Scientist at the Terasaki Research Institute from August 2008 to September 2010. Matthew started their career as a Clinical Pharmacist at Penn Medicine, University of Pennsylvania Health System from June 2004 to May 2005 and later served as the Pharmacy Clinical Coordinator (Head of Pharmacy Clinical Services) at Mercy Catholic Medical Center from June 2005 to December 2006.

Matthew Everly, PharmD has a strong educational background in pharmacy. Matthew obtained their Doctor of Pharmacy (PharmD) degree from the University of Cincinnati James L. Winkle College of Pharmacy in 2002, preceded by a Bachelor of Pharmacy (BPharm) degree from the same institution in 2001. Their focus of study during these years is not specified.

Following their PharmD, Matthew pursued a Transplant Pharmacy Residency at the University of Cincinnati in 2007, where they gained specialized knowledge and skills in the field of transplantation. Additionally, they completed a Transplantation Clinical Research Fellowship at the University of Cincinnati in 2008, further enhancing their expertise in this area.

Matthew Everly also holds several certifications. Matthew is a Board Certified Pharmacotherapy Specialist (BCPS), which they obtained from the BPS - Board of Pharmacy Specialties in 2007. Matthew is also a Registered Pharmacist in both the State of California and the State of Ohio, indicating their active licensure to practice pharmacy in these states. The specific months and years of obtaining these certifications are not provided.